The New Models of Care workstream seeks to change how different providers organise themselves in order to deliver better care for patients. We are working with our partners in the national Cancer Vanguard to make this commitment a reality.
Medicines optimisation is a key theme running throughout our New Models of Care programme. Recognising that the pharmaceutical industry would play a key role in any successful programme, we challenged organisations to submit proposals that would help us to deliver improvements in the use of cancer medicines.
The challenge to industry – the Pharma Challenge – was issued with the support of the Association of British Pharmaceutical Industries (ABPI) and the Ethical Medicines Industry Group. The proposals had to meet at least one of the following criteria:
- They enhance our understanding of a patient’s experience
- They promote the evidence-based choice of medicines
- They ensure medicines use is as safe as possible
- They make medicines optimisation part of routine practice.
The response was extremely impressive - nearly 40 companies submitted proposals, all of which outlined innovative ways of improving medicines use. The national Cancer Vanguard will shortly be announcing a series of pharma partnership working projects to look at ways we can improve the delivery of medicines to cancer patients, including closer to patients’ homes.
The UCLH Cancer Collaborative is also working to produce a set of standards that will act as a ‘kitemark’ of quality for chemotherapy services and exploration of new radiotherapy delivery models.
For more information about the New Models of Care workstream, please contact firstname.lastname@example.org